Neoplasm malignant
Not recruitingA Study of GEN1047 in Patients with Solid Tumors: First Time Use in Humans
- Disease:Neoplasm malignant
- Substances:Gen1047
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Gen1047
- Sponsor:Genmab A/S
Rare diseases
Investigational molecules
Locations
Back to the Netherlands796 clinical trials in Rotterdam, The Netherlands across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on frontotemporal dementia treatments and management of migraine in relation to obesity. Studies include evaluation of new therapeutic compounds and their effects on neurological conditions.
Research aims to improve patient outcomes through targeted therapeutic approaches and innovative treatment methods.
Comprehensive studies targeting various forms of cancer, including advanced gastric cancer and bladder cancer. Research includes innovative imaging techniques and combination therapy approaches.
Focus on developing more effective treatment strategies and improving diagnostic capabilities.
Clinical trials addressing obesity and related metabolic conditions, including innovative approaches to weight management and metabolic disease treatment. Studies evaluate new therapeutic options for thyroid disorders.
Research focuses on developing effective treatments for complex metabolic conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.